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ABSTRACT
Introduction: Immobilisation in the intensive care unit
(ICU) leads to muscle weakness and is associated with
increased costs and long-term functional disability.
Previous studies showed early mobilisation of medical
ICU patients improves clinical outcomes. The Surgical
ICU Optimal Mobilisation Score (SOMS) trial aims to
test whether a budget-neutral intervention to facilitate
goal-directed early mobilisation in the surgical ICU
improves participant mobilisation and associated
clinical outcomes.
Methods and analysis: The SOMS trial is an
international, multicentre, randomised clinical study
being conducted in the USA and Europe. We are
targeting 200 patients. The primary outcome is average
daily SOMS level and key secondary outcomes are ICU
length of stay until discharge readiness and ‘mini’
modified Functional Independence Measure (mmFIM)
at hospital discharge. Additional secondary outcomes
include quality of life assessed at 3 months after
hospital discharge and global muscle strength at ICU
discharge. Exploratory outcomes will include:
ventilator-free days, ICU and hospital length of stay and
3-month mortality. We will explore genetic influences
on the effectiveness of early mobilisation and centre-
specific effects of early mobilisation on outcomes.
Ethics and dissemination: Following Institutional
Review Board (IRB) approval in three institutions, we
started study recruitment and plan to expand to
additional centres in Germany and Italy. Safety
monitoring will be the domain of the Data and Safety
Monitoring Board (DSMB). The SOMS trial will also
explore the feasibility of a transcontinental study on
early mobilisation in the surgical ICU.
Results: The results of this study, along with those of
ancillary studies, will be made available in the form of
manuscripts and presentations at national and
international meetings.
Registration: This study has been registered at
clinicaltrials.gov (NCT01363102).
ARTICLE SUMMARY
Article focus
▪ Early mobilisation is important for critically ill
patients who are at risk of developing intensive
care unit (ICU) acquired weakness.
▪ ICU-acquired muscle weakness is associated
with increase in duration of mechanical ventila-
tion, ICU length of stay and mortality.
▪ In the surgical ICU, contraindications to early
mobilisation exist in subsets of patients. We
evaluate the value of the Surgical ICU Optimal
Mobilisation Score (SOMS) guided algorithm for
goal-directed early mobilisation.
Key messages
▪ This protocol presents an international,
multicentre, randomised controlled clinical trial
in the surgical ICU analysing the efficacy of
goal-directed early mobilisation compared to
standard of care on clinically important
outcomes.
▪ The results of this trial should be broadly gener-
alisable and provide a cornerstone for future
early mobilisation research in surgical ICU.
Strengths and limitations of this study
▪ International, multicentre, randomised controlled
clinical trial.
▪ Straightforward, intuitive and easily implementa-
ble algorithm designed by a multidisciplinary
team interested in critical care medicine.
▪ No specific budget expenditure to implement the
SOMS algorithm.
▪ Exploratory testing of genetic polymorphisms,
which may explain parts of the variance in the
effectiveness of early mobilisation.
▪ Contamination bias may occur when clinical
experience with intervention activities affects
mobilisation therapy in the standard of care
group.
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Background
Previous studies have shown that early mobilisation
improves outcomes in the medical intensive care unit
(ICU).
1–3 Currently, there is little data on the effects of
early mobilisation in the surgical ICU; however, there is
some fear that surgical patients could be harmed by pre-
mature mobilisation following major surgery.
4 The risks
of immobilising patients are well established,
45espe-
cially ICU-acquired weakness.
67ICU-acquired weakness
is associated with increased risk of aspiration,
8 increased
length of hospital stay (LOS)
9 and increased mortality.
9
Moreover, the consequences of ICU-acquired muscle
weakness can result in persistent functional disability for
at least 5 years,
10 11 which affects the quality of life of
ICU survivors.
12
Moderate exercise can mitigate the adverse conse-
quences associated with immobility by improving muscle
strength
13 and physical function
3 and it can translate into
improved patient outcomes. Three prospective studies
conducted in the medical ICU demonstrate improved
outcomes when mobilisation was made a priority: patients
have less exposure to benzodiazepines,
2 shorter durations
of delirium,
23less time on mechanical ventilation,
3 fewer
ICU days,
12fewer hospital days
12and better functional
independence at hospital discharge.
3
Mobilising patients following surgery has been part of
the surgical culture for over a century.
14 15 A variety of
surgical procedures and conditions have been deemed
safe for early mobilisation, including blunt trauma,
16 full
thickness skin grafts,
17 left ventricular assist device place-
ment
18 and lung surgery.
19 In elderly patients, early
mobilisation following treatment for acetabular fractures
has improved outcomes.
20 Establishing early mobilisa-
tion as safe following certain procedures, such as periph-
eral angioplasty,
21 has helped allocate hospital resources
more efﬁciently.
22 However, there is evidence that early
mobilisation may have negative effects in disease-speciﬁc
subgroups, such as brain trauma.
23
In surgical ICU, research on early mobilisation is
limited. Barriers to mobilisation include surgical wound
pain, musculoskeletal trauma, unstable fractures, open
wounds, drains and other medical devices physically
attached to the patient and the patient’s proximity to or
from surgery. Perceived difﬁculties to mobilisation also
depend on the profession and training of the healthcare
provider.
24 In surgical patients, optimally tailored mobil-
isation is desirable to avoid potential morbidity from
excessive or inappropriate mobilisation.
In response, our team, including critical care nurses,
physical therapists and physicians, developed the
Surgical ICU Optimal Mobilisation Score (SOMS)
24 and
we apply it as an algorithm for goal-directed early mobil-
isation in the surgical ICU. SOMS is a simple ‘0’ to ‘4’
score ranging from ‘No activity’ to ‘Ambulation.’ The
achieved SOMS on the ﬁrst day of surgical ICU admis-
sion is an independent predictor of surgical ICU and
hospital LOS, and in-hospital mortality.
25 SOMS
facilitates the nominal classiﬁcation of mobility in the
surgical ICU and has adequate inter-rater reliability.
25
Objectives
The primary objective is to
1. Evaluate the effectiveness of the SOMS-guided algo-
rithm for goal-directed early mobilisation compared
to standard of care on the primary outcome of
average daily patient mobilisation, and the key sec-
ondary outcomes of surgical ICU LOS until discharge
readiness and patient functional mobility at surgical
ICU and hospital discharge.
2. Explore the effects of goal-directed early mobilisation
compared to standard of care on quality of life after
hospital discharge and global muscle strength at ICU
discharge.
The secondary objectives are to
1. Generate data for hypotheses and power calculations
for future trials.
2. Analyse relationships between polymorphisms in
genes associated with circadian rhythm, sleep cycle
and muscle homoeostasis and response to early
mobilisation treatment.
Hypotheses for the primary outcome
1. Participants in the intervention group, receiving
SOMS-guided goal-directed early mobilisation treat-
ment, compared with standard care will have a higher
average daily SOMS level, shorter length of surgical
ICU stay and better functional mobility at discharge.
2. Participants in the intervention group, receiving
SOMS-guided goal-directed early mobilisation treat-
ment, compared with standard care will have better
quality of life following hospital discharge and better
muscle strength at surgical ICU discharge.
METHODS AND ANALYSIS
Trial design
The SOMS group has designed an international, multi-
centre, randomised controlled trial. An outline of the
study design and daily work is provided in ﬁgure 1.W e
pledge to adhere to the CONSORT 2010 Statement
26
for reporting of our trial.
Subjects
All adult surgical ICU patients who have been ventilated
for less than 48 h and are expected to continue ventila-
tion for at least another 24 h at the time of screening,
and who meet baseline criteria for functional independ-
ence (Barthel Index Score ≥70 2 weeks prior to admis-
sion
27) are considered for the study. Table 1 contains
the exclusion criteria.
Recruitment timeframe
This trial is occurring currently in the surgical ICU at
three academic medical centres in the USA with expec-
tations of expansion to one academic medical centre in
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and is expected to be complete in 3 years.
Recruitment and randomisation
The local investigator will screen surgical ICU patients
daily and patients will be included into the study
according to locally dependent consenting standards.
Participants will be immediately randomly allocated into
the intervention or standard of care group by study staff.
We stratify according to Glasgow Coma Scale (GCS; ≤8,
>8) and Acute Physiology and Chronic Health
Evaluation II (APACHE II; ≤12, >12) at each centre.
Figure 1 Participant progression
through the study protocol. GCS,
Glasgow Coma Scale; ICU,
intensive care unit; LOS, length of
stay; mmFIM, ‘mini’ modified
Functional Independence
Measure; MRC, Medical
Research Council; SOMS,
Surgical ICU Optimal Mobilisation
Score.
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APACHE II ≤12; (2) GCS ≤8, APACHE II >12; (3) GCS
>8, APACHE II ≤12; and (4) GCS >8, APACHE II >12.
Into each subgroup (1–4), the stratiﬁed randomisation is
restricted to 50:50 (intervention : standard of care)
initially.
Administrative structure
The clinical coordinating centre is at the Massachusetts
General Hospital in Boston, Massachusetts, USA and is
responsible for preparation of the protocol and revisions,
managing communications and publishing study results. In
each surgical ICU there is a clinical member of the unit
(eg, a clinical nurse specialist or a nurse practitioner) who
helps facilitate the implementation of SOMS-guided goal-
directed early mobilisation (see box 1).
Surgical Optimal Mobilisation Score (SOMS) algorithm
The SOMS algorithm for goal-directed mobility ranges
from ‘0—No mobility’ to ‘4—Ambulation’ (ﬁgure 2).
The intermediate steps are ‘1—Passive Range of
Motion,’‘ 2—Sitting,’ and ‘3—Standing.’ A SOMS of ‘0’
indicates that no mobilisation should be considered due
to the clinical state of the participant. A SOMS of 1 indi-
cates the nurse can perform passive range of motion
exercises while the patient is in bed. The passive range
of motion entails ankle dorsiﬂexion, knee and hip
ﬂexion, hip abduction, shoulder ﬂexion, abduction and
external rotation, wrist ﬂexion and elbow ﬂexion. The
magnitude and frequency of passive range of motion is
based on clinical discretion. A participant achieves a
SOMS of 2 if able to sit either on the side of the bed or
on a chair. A SOMS of 3 indicates that a patient is able
to stand with or without assistance. The highest level a
patient can achieve is a SOMS of 4, in which the patient
is able to ambulate.
Standard of care
Surgical ICU nurses conduct daily neurological assess-
ments using the Richmond Agitation Sedation Scale for
arousal and the Confusion Assessment Method for ICU
for delirium. Participants who are documented as posi-
tive for the Confusion Assessment Method for ICU will
be considered delirious. Participants in the study as well
as control groups are managed by goal-directed sedation
and undergo daily decreases in sedatives and/or narco-
tics. Contraindications to daily attempts to decrease sed-
ation are persistent neuromuscular blockade, sedative
infusion for active seizures or alcohol withdrawal, persist-
ent agitation, active myocardial ischaemia and elevated
intracranial pressure. All patients receive early enteral
feeding and patients with high glucose concentrations
are treated with protocol-based insulin regiments.
Liberating patients from mechanical ventilation is per-
formed via a protocol, with the decision to extubate
made by the clinical team. Daily spontaneous breathing
trials occur with all participants as long as there are no
contraindications (critically elevated intracranial
Box 1 The role of the Surgical Intensive Care Unit
Optimal Mobilisation Score (SOMS) facilitator pertaining to
intervention and standard of care participants
Roles of the SOMS facilitator
Standard of care
▸ Record activity level and SOMS achieved
▸ Identify adverse events and report them to study staff
Intervention
▸ Facilitate the discussion related to setting a daily SOMS goal
with the rounding team, nurses, physical therapists and
respiratory therapists
▸ Assist nurses with mobilisation strategies to achieve SOMS
goal
▸ Give advice on how to address barriers to early mobilisation
▸ Present barriers to mobilisation to rounding team for solutions
▸ Identify adverse events and report them to study staff
Table 1 Study exclusion criteria
Exclusion criteria Justification
Irreversible disorders with 6-month mortality estimated at greater than 50% Incomplete outcome data
Rapidly developing neuromuscular disease Incomplete study procedures
Cardiopulmonary arrest Unable to ensure future independent
mobility
Brain injury with Glasgow Motor Score <5 Unable to ensure future independent
mobility
Elevated intracranial pressure Intervention contraindicated
Rupture/leaking aortic aneurysm Intervention contraindicated
Acute myocardial infarction before peak troponin has been reached Intervention contraindicated
Absent lower extremities Incomplete study procedures
Unstable fractures Intervention contraindicated
Prolonged hospitalisation >5 days at enrolment hospital or at an outside
hospital
Potential confounding factors
Pregnancy (women 18–55 years old) Intervention contraindicated
Enrolment in another clinical trial Potential confounding factors
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cant haemoptysis, haemodynamic instability, active myo-
cardial infarction, an unstable airway, fraction of
inspired oxygen >0.6, pressure control >20 cm H2O,
positive end-expiratory pressure ≥8c mH 2O, expiratory
volume ≥15 L/min or extracorporeal life support).
Intervention
The intervention (SOMS-guided goal-directed early
mobilisation) will begin on the day following consent
unless signed consent is received prior to the surgical
ICU team conducting morning rounds. The SOMS algo-
rithm (ﬁgure 2) will be discussed during morning
rounds when the team deﬁnes a SOMS goal for the day
with the assistance of the SOMS facilitator. The SOMS
algorithm establishes a minimum standard for partici-
pant advancement to the next mobilisation level and
contains polar (yes/no) and non-polar questions.
Clinical staff member involved with mobilising the par-
ticipant should be able to verify the polar questions (ie,
intracranial pressure <20 cm H2O). The non-polar ques-
tions which involve clinical judgment (ie, no excessive
predicted mortality within the next 24 h) are discussed
with the assistance of the SOMS facilitator.
Once the mobilisation goal has been determined, a
sign will be posted at the participant’s bedside with the
goal for the day. The bedside nurse will work with the
participant to achieve the goal. Prior to afternoon
rounds, the nurse will document the highest achieved
SOMS for the day. If the goal SOMS was neither met
nor exceeded, the nurse documents barriers to mobilisa-
tion. These barriers will be discussed and attempts will
be made to mitigate these barriers (ie, pain, anxiety,
haemodynamic or respiratory concerns) in order to
meet the SOMS goal for the following day.
Blinding
Given the design of the SOMS trial, blinding to the
primary outcome is impossible. The assessors of the key
secondary outcome of ‘mini’ modiﬁed Functional
Independence Measure (mmFIM) and the secondary
outcome of short form 36 (SF-36) 3 months after hos-
pital discharge will be blinded to the study assignment.
The data analyst will also be blinded to the study group
assignments.
Outcome measures
The primary outcome is mean achieved SOMS level over
the course of the ICU stay and this will be recorded
daily until ICU discharge. The key secondary outcome
of ICU LOS until discharge readiness will be recorded
once determined by the clinical team. The key
Figure 2 Surgical ICU Optimal Mobilisation Score (SOMS) algorithm for goal-directed early mobilisation.
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mobility, will be assessed at hospital discharge.
The secondary outcome of quality of life obtained
through SF-36 survey will be completed at least 3 months
following hospital discharge. The secondary outcome of
Medical Research Council (MRC) Scale for testing
global muscle strength will be administered daily while
in ICU.
Exploratory outcomes for this study will include ICU
LOS, hospital LOS, in-hospital mortality, 3-month mor-
tality, discharge disposition, ICU delirium-free days,
ventilator-free days, ICU sedation-free days, average daily
morphine equivalent dose (mg), neuromuscular block-
ing agent-free days, vasopressor-free days, corticosteroid
days, daily high serum glucose (mg/dL) and daily high
serum sodium (mEq). All outcome measures will be
monitored from study day 1 and stop with surgical ICU
discharge unless otherwise indicated, such that a time-
dependent analysis of positive and negative outcomes
can be conducted in all patients. The predeﬁned period
for outcome-free days is 28 days and any participant who
dies prior to day 28 will have all subsequent days
counted as not outcome free. We will consider all days
following surgical ICU discharge as outcome free.
‘Mini’ modified Functional Independence Measure
A trained and blinded member of the study staff will
determine mmFIM. mmFIM is a shortened version of
modiﬁed Functional Independence Measure (mFIM)
and contains only two (locomotion and transfer) of the
ﬁve components from mFIM to better reﬂect the func-
tional activities of critically ill patients.
28 Like mFIM,
mmFIM is scored from 1 to 4. A score of 1 indicates
near or complete dependence for the aforementioned
skill, 2 indicates partial independence, 3 indicates inde-
pendence with activity setup or adaptive equipment and
4 indicates complete independence. Previously reported
data have indicated a linear relationship between the
standard FIM and the mFIM scales.
29 The mmFIM data
will be analysed dichotomously, with a score of 4 indicat-
ing complete independence and scores of 1–3 indicating
activity dependent on others or adaptive equipment.
Short form 36
SF-36 (SF-36v2; QualityMetric Inc, Lincoln, Rhode
Island, USA) is a generic health status questionnaire vali-
dated for use across diverse populations.
30 It comprises
36 questions which provide summaries on physical, emo-
tional and social function. Data are gathered using eight
domains: physical function, social function, role limita-
tions secondary to physical health, role limitations sec-
ondary to emotional well-being, bodily pain, vitality,
general mental health and general health.
31 SF-36 is
applied in our study to assess participant’s quality of life
3 months following hospital discharge.
MRC manual muscle strength testing
MRC is a measure which reliably predicts in-hospital
mortality, surgical ICU LOS and hospital LOS.
9 Study
staff will aim to measure MRC daily. MRC manual
muscle strength testing may only be assessed if a partici-
pant’s level of sedation (Richmond Agitation Sedation
Scale ≥−1), attention span and ability to follow instruc-
tions are adequate. The ability to follow instructions will
be gauged by asking the patient a series of 1-step and
2-step instructions, a modiﬁcation of the De Jonghe
et al
6 approach which we have previously reported.
9 If
the patient is unable to complete the steps or deemed
not alert, the test will not be conducted for that day.
When appropriate, MRC will be conducted daily while
the patient is in the surgical ICU. The MRC data will be
analysed as a continuous variable.
Sample size estimation
The sample size calculation is informed by data from
Kasotakis et al
25 and Schweickert et al.
3 From Kasotakis
et al
25 we predict an intergroup SOMS difference of 1
±1.5 and a correlation of SOMS to surgical ICU LOS of
r=−0.54. From Schweickert et al
3 we predict an incidence
of an mmFIM score of 4 (complete independence for
the activity evaluated) of 59% in the intervention group
and 35% in the standard of care group at hospital dis-
charge.
3 Allowing for an expected 11% mortality rate
and 11% attrition due to dropouts, enrolling 200 partici-
pants, 100 in each group, will provide us with a power of
>80% to identify an intergroup difference with an α
error of 0.05.
Enrolment goals will be 1–4 participants/site/month.
Site enrolment will be evaluated every 3 months through
communications relayed by site-lead investigators and
designated representatives with the clinical coordinating
centre. Any unexpected delays in enrolment will be dis-
cussed between the clinical coordinating centre and the
respective site. If the delays in enrolment are due to lim-
itations imposed by the inclusion and exclusion criteria,
changes will then be considered. Any changes to these
criteria will require the approval of the Data and Safety
Monitoring Board (DSMB) and the institutional review
board (IRB) of the respective institution. If enrolment is
persistently below expectations and no changes to the
inclusion or exclusion criteria are identiﬁed, additional
clinical sites may be included.
Statistical methods
The study analysis will be by intention to treat. Summary
statistics of mean and SD, frequency and percentage will
be generated, respectively, for continuous and categor-
ical/ordinal variables by the stratiﬁcation based on GCS
and APACHE II. The association between the outcome
variables and stratiﬁcation will be evaluated using
ANOVA and χ
2 test, respectively.
The main outcomes of the study will be tested using a
hierarchical sequence so the hypotheses, in an a priori
speciﬁed order, can be tested with an α error of 0.05
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32–34 The out-
comes will be tested in this predeﬁned order: mean
daily SOMS level, surgical ICU LOS until discharge
readiness and mmFIM score at hospital discharge. If a p
value is larger than 0.05, the procedure has to stop and
no conﬁrmatory conclusions can be based on outcomes
at or after the outcome whose null hypothesis was the
ﬁrst that was not rejected.
The average SOMS level is calculated using the achieved
mobility scores recorded daily during each participant’s
ICU stay. Trend tests will be used to assess the association
between average ICU stay and other outcomes over levels
of SOMS. For the key secondary outcomes, time-dependent
survival analysis will be employed to assess relationships
between the duration of admission and SOMS, with ventila-
t o rf r e ea n dt h el i k et ob ec o n s i d e r e da st i m e - d e p e n d e n t
covariates. Statistical signiﬁcance will be evaluated at
α=0.05. All analyses will be conducted by a statistician
blinded to the intervention.
Data collection
Baseline descriptive data collection will occur on the day
of enrolment and include age, gender, race, ethnicity,
height, weight, best preadmission SOMS, admission diag-
nosis, pre-existing comorbidities (diabetes mellitus, cor-
onary artery disease, asthma, peripheral vascular disease,
renal failure, psychiatric disease, musculoskeletal disease
or other) and admitting surgical team.
Clinical data will be collected daily during the surgical
ICU admission, including highest blood glucose level,
highest sodium concentration, model Richmond
Agitation Sedation Scale, Confusion Assessment Method
for ICU and greatest pain score (1–10). Total daily dose
will be collected for speciﬁc participant medications:
neuromuscular blocking agents, narcotics, sedatives, anti-
psychotics, intravenous vasopressors and glucocorticoids.
Physical therapy visits will be recorded. Discharge readi-
ness is deﬁned as the time when surgical ICU team
requests a non-ICU room for the participant. Data will be
uploaded to a secure database (REDCap). Data stored on
REDCap are coded without protected information.
Safety guidelines for mobilisation
Oxygen saturation, ECG, blood pressure and heart rate
will be monitored throughout the study as indicated by
clinical staff. The healthcare provider will be responsible
for determining whether the study intervention should
be stopped in each participant. In the situation of severe
and/or persistent hypoventilation, or when blood pres-
sure or heart rate changes substantially to a threshold
deﬁned during morning rounds by the surgical ICU
care team, mobilisation therapy will be terminated.
Additionally, the SOMS algorithm has been designed by
a multidisciplinary team to ensure the safety of the par-
ticipant. Participants are not to be advanced to greater
mobilisation levels unless they fulﬁl speciﬁc safety-
focused criteria (ﬁgure 2).
Adverse events
Adverse events will be recorded daily. Nursing charts
and documentation, as well as physicians’ notes will be
reviewed daily to identify potential adverse events.
All adverse events will be recorded and are deﬁned as
any unfavourable and unintended signs, symptom or
disease chronologically associated with mobilisation
therapy. The relationship of any adverse event to mobil-
isation therapy will be assessed by the investigator and
qualiﬁed by association (not related, unlikely, possibly,
probably or deﬁnitely related) and intensity of the effect
(mild, moderate or severe). All adverse events will be
summarised by the treatment group and reported to
DSMB at the time of review.
Adverse events will be monitored daily, and, when
appropriate, reported to the local human research com-
mittee. Severe adverse events include fall to knees, endo-
tracheal tube removal and oxygen desaturation to less
than 80%.
3 Severe adverse events related to arterial
blood pressure will be deﬁned individually by the clin-
ical team since this condition is greatly dependent on
pathology, treatment and the overall clinical milieu.
Role of DSMB
DSMB has been created and comprises physicians with
relevant critical care and medical experience. The
members are not involved in the study and will be com-
pletely independent of any study-related patient recruit-
ment and data collection. One interim review focused
on safety data will be completed when data are available
at 3-month follow-up on 100 participants.
ETHICS AND DISSEMINATION
Consent
As this is an international trial, the process of informed
consent may be different between sites and will be
dependent on cultural and national standards.
35 For the
majority of participants in our study written consent will
be provided by a healthcare proxy. Informed consent will
be obtained from each potential participant’s healthcare
proxy by study staff. The study staff receiving the consent
will give a copy of the IRB approved informed consent
form to the healthcare proxy and/or potential partici-
pant. The healthcare proxy and/or potential participant
will have adequate time to read the informed consent
form, evaluate the risks of the study, consult with any
family members or clinicians requested and ask questions
to the study staff. If the healthcare proxy and/or patient
decides to participate then the informed consent form
will be signed. Participants will be informed of their par-
ticipation in the study following resolution of their critical
illness and any residual delirium.
Ancillary studies
The SOMS trial will be conducted in the USA and in
Europe. A validation trial of the SOMS has been con-
ducted in English in the USA.
25 Additional validation
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Italy and Germany, respectively, are planned. This study
lends itself to a qualitative assessment of culture change
in the surgical ICU from a unit with predominantly
immobilised patients to one with a focus on early mobil-
isation. We have the opportunity to assess the manner in
which patients are mobilised internationally and discuss
and share any best practices that are identiﬁed.
Alongside of our primary trial, participants will be
able to opt in to a related, hypothesis-generating
exploratory genetic study. We anticipate wide variability
in the effectiveness of early mobilisation and speculate
that some of the variability are related to circadian dysre-
gulation. In ICU patients, decreased total sleep time,
decreased deep (restorative) sleep, fragmented sleep as
well as altered circadian patterns have been
reported.
36 37 Other preliminary data suggest that treat-
ments to improve circadian disruption such as intermit-
tent light therapy may facilitate early ambulation in
critically ill patients.
38 We also believe some of the vari-
ability in the effectiveness of early mobilisation is related
to inherent qualities of the muscles. Therefore, with an
exploratory intention, we will evaluate whether the exist-
ence of single-nucleotide polymorphisms in genes asso-
ciated with sleep, circadian rhythm and muscle function
explain some variance in the effectiveness of early
mobilisation in ICU patients (ﬁgure 3).
We will conduct genetic tests to ﬁnd associations
between known polymorphisms related to sleep quality,
circadian rhythm and muscle homoeostasis, and muscle
strength, mobility and surgical ICU outcomes.
Speciﬁcally, we will focus on polymorphisms in CLOCK,
39
NPAS2,
40 PER2,
41 PER3,
42 PDE4D,
43 MUC1,
44
ATP2B1,
44 45 DCDC5,
44 TRPM6,
44 SHROOM3
44 46 and
MDS1
44 genes, which are associated with sleepiness, sleep
phase and potentially respiratory muscle weakness. If
consent is received for the genetic study, blood is drawn
and stored prior to transport to the Center for Human
Genetic Research at Massachusetts General Hospital
where blood samples will be processed and genetic ana-
lysis performed. All laboratory specimens will be stored
with a coded identiﬁcation to maintain privacy.
Figure 3 An ancillary study to explore genetic mechanisms contributing to the effectiveness of early mobilisation in the surgical
intensive care unit (ICU). We target a subset of genes linked to either sleep and circadian rhythm or muscle function. These
candidate genes are part of a greater set of genes and polymorphisms that may be responsible for some of the variance of
response to goal-directed early mobilisation. Genetic tests will be performed as an ancillary study linked to the Surgical ICU
Optimal Mobilisation Score (SOMS) protocol.
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Open AccessPublication and dissemination
The results of this study along with those of ancillary
studies will be publicised in the form of presentations at
national and international meetings. The complete
study and conclusions regarding the primary objectives
will be presented in manuscript form.
DISCUSSION
This article presents the protocol and data analysis plan
for the SOMS trial; an international, multicentre, rando-
mised controlled clinical study evaluating SOMS-guided
goal-directed early mobilisation and its capacity to
improve patient mobilisation, reduce surgical ICU LOS
and improve other surgical ICU outcomes. Research
associated with mobilisation in the medical ICU is robust
and the associations with improved clinical outcomes
strong.
1–3 We believe that the SOMS algorithm will help
surgical ICU clinicians avoid many of the risks of immo-
bilisation, including atrophy and decreased contractile
function of skeletal muscles
54 7and the diaphragm,
48
motor and sensory neuropathy
49 and persistent func-
tional deﬁcits
10 11 likely due to ICU acquired weakness,
67
We also believe the structure of the SOMS algorithm will
help surgical ICU clinicians minimise the hazards of
mobilising patients: dislodgement of medical devices,
mechanical trauma, haemodynamic instability
24 or
hypoxia secondary to respiratory failure
50 (ﬁgure 4).
The strength of the SOMS trial comes from three fun-
damental characteristics embedded in the design: (1)
simplicity, (2) clinical team focus and (3) utilisation of
resources already available. SOMS-guided goal-directed
early mobilisation is straightforward, progressive and
intuitive. It was created with input from the ﬁelds of
nursing, physical therapy, physiatry and critical care to
ensure safety and function. It is written in clinically
precise and mutually comprehensible language. The
process of setting a mobilisation goal should add
minimal time to morning rounds. The role of the SOMS
facilitator to assist in goal setting and assess the partici-
pant’s progress will require a few minutes spread
throughout the day. The results of this study will be gen-
eralisable to the broader clinical community such that
the study ﬁnding will be externally valid and should
guide clinical standards for early mobilisation, or ‘preha-
bilitation,’ in the surgical ICU.
The SOMS algorithm allows nurses to readily contrib-
ute to goal setting on rounds and it provides structure
for the nurses to mobilise the participants. The act of
delivering the intervention, mobilising participants from
the bed to sitting and so forth, takes time. While we
believe the SOMS algorithm makes efﬁcient use of exist-
ing resources, we acknowledge that shifting resources
towards mobilisation may be associated with opportunity
costs under certain circumstances.
SOMS is a thoughtful and uncomplicated intervention.
However, owing to the nature of the research, there are
notable limitations. One limitation in the study is the inabil-
ity to blind the assessor of a participant’sa c h i e v e dS O M S .
For study participants, the achieved SOMS is obtained daily
from the participant’s nurse who is unblinded and part of
the intervention. The achieved SOMS is checked against
the nursing documentation. For control participants, the
achieved SOMS is obtained by the clinical SOMS facilitator
during regular afternoon rounds. The numbers obtained
by the nurses and the SOMS facilitator are again checked
against the nursing chart.
A second limitation is that we do not add any add-
itional personnel resources to accomplish the daily
SOMS goal and this is an environment which occasion-
ally has difﬁculty meeting its current mobilisation
goals.
51 We believe the SOMS algorithm for goal-
directed early mobilisation is complementary to the phil-
osophy of nursing and will be ﬂuidly incorporated into
their systems with limited effect on their workload.
Foremost, the SOMS algorithm should improve
mobility-related communication between providers, and
thus lead to more frequent mobilsation of patients and a
change in mobilisation culture in the surgical ICU.
However, there is the possibility that this budget-neutral
intervention may not improve mobilisation adequately to
draw conclusions, and a dedicated mobilisation specialist
Figure 4 Potential benefits and adverse effects of SOMS-guided early mobilisation. The SOMS algorithm is designed to
carefully and incrementally advance mobilisation. On the basis of the knowledge gathered in the medical ICU, early mobilisation
leads to improved clinical outcomes such as fewer days in the ICU and better functional mobility at discharge. However, while
using the bridge of goal-directed early mobilisation, possible complications and side effects of mobilisation must be considered
like pain and increased oxygen consumption. ICU, intensive care unit; PROM, passive range of motion; SICU, surgical intensive
care unit; SOMS, Surgical ICU Optimal Mobilisation Score.
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1–3 may
be necessary.
The adoption of patient mobilisation into the surgical
ICU prompts a third limitation: culture shift from immo-
bilised patients
52 to mobilised patients. As nurses gain
more experience mobilising critically ill patients due to
their patients’ participation in our study, they will
become more comfortable applying this same concept
to all of their patients: intervention, control and other.
Consequently, we expect mobilisation in the standard of
care group to increase with time, which may lead to a
type II error. The multicentric trial design with a high
sample size utilising individual randomisation may help
minimise contamination.
53
Furthermore, throughout the world and even in the
most afﬂuent nations, mobilising patients in the surgical
ICU is performed by a variety of different healthcare
providers with different training backgrounds
24: nurses,
nursing assistants, students, respiratory therapists, phys-
ical therapists and physicians of different specialties.
Additionally, the availability of resources, both assistive
equipment
52 and personnel, differs between a tertiary
care hospital in Europe and in the USA. Accordingly, a
speciﬁc algorithm with decision points explicitly requir-
ing ‘yes’ and ‘no’ answers to advance, stall or regress the
mobilisation goal must accommodate cultural, linguistic
and resource-based variation. Therefore, our goal-
directed early mobilisation algorithm will be identical
across all centres relative to the stages of mobilisation
and the focus on promoting early and clinically appro-
priate mobilisation, but the algorithm will have minor,
local adaptations.
Finally, in consideration of the minor effect that
genetic differences in sleep, circadian rhythm and
muscle homoeostasis may have on variance in surgical
ICU outcomes, our study may be underpowered to iden-
tify genetic inﬂuence on surgical ICU outcomes.
CONCLUSION
This manuscript provides a description of our study
protocol and analysis plans for the SOMS multicentre
randomised control trial. Beyond evaluating the effects of
goal-directed early mobilisation on clinical outcomes and
patient mobility, this study is designed to maximise the
efﬁciency of existing resources without requiring any new
personnel or funding. Furthermore, the design of this
study lends itself to ancillary studies related to the cultural
issues associated with mobilisation of surgical ICU
patients. This trial is an opportunity to use goal-directed
early mobilisation to improve surgical ICU clinical out-
comes safely without adding to the hospital expenses.
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